Skip to main content

Table 1 Clinical Information for Samples

From: Profiling of T cell repertoire in peripheral blood of patients from type 2 diabetes with complication

SampleID

Gender

Age

BMI

Comorbidity information

Complications information

Current therapy

Family history of diabetes

fasting blood glucose (FBG)

glycosylated hemoglobin (HbA1c)

total cholesterol (TC)

triglyceride (TG)

high density lipoprotein-cholesterol (HDL-C)

low-grade lipoprotein cholesterol (LDL-C)

S3_12

female

59

26.56

YES

LCV

NA

YES

4.73

5.6

4.31

1.32

1.04

2.63

S3_14

male

76

23.85

YES

LCV

Isophane Protamine Biosynthetic Human Insulin Injection, Metformin, Acarbose Tablets

NO

18.84

10.8

5.73

1.56

1.13

3.91

S3_17

male

63

25.2

TES

LCV

Metformin 0.5g bid;Dapagliflozin 10mg qd

YES

6.6

6.3

6.24

0.95

1.59

4.19

S3_18

female

63

25

YES

LCV

Protamine Zinc Insulin Injection, acm: 16u, acv: 14u

YES

5.59

6.9

6.29

0.43

1.29

1.56

S3_21

male

59

22

YES

LCV

Metformin 0.5g bid;Acarbose Tablets 50mg tid;Insulin Aspart 30 Injection

NO

7.84

7.2

3.75

1.03

1.02

2.37

S3_22

male

47

26.8

YES

LCV

Metformin 0.5g bid;Dapagliflozin 10 mg qd

YES

6.49

5.7

4.2

0.56

1.36

2.47

S3_23

male

54

23

YES

LCV

Metformin 0.5 g bid;Acarbose Tablets 50 mg tid

YES

7

7.5

5.9

3.65

0.76

3.75

S3_2

male

59

26.2

YES

LCV

Metformin 0.5g bid;Empagliflozin 10mg qd

YES

5.69

6.1

4.78

0.61

1.58

2.64

S2_14

male

42

22

YES

NE

Metformin 0.5g bid;Dapagliflozin 10mg qd;Acarbose Tablets acv 50mg

YES

9.93

9.2

5.25

0.66

1.44

3.55

S3_19

male

68

24

YES

NE

Metformin 0.5g bid;Dapagliflozin 10mg qd;Glimepiride 10mg qd

YES

8.3

7

4.12

2.32

1.2

3.67

S3_20

male

61

21

YES

NE

Metformin 0.5g bid;Dapagliflozin 10mg qd

YES

8.56

7.5

3.19

1.12

0.72

1.95

S3_24

female

70

24

YES

NE

Metformin 0.5 g bid;Dapagliflozin 10 mg qd

NO

6.91

7.1

5.7

1.17

1.51

3.38

S3_5

female

73

24.6

YES

NE

Metformin 0.5g bid;Dapagliflozin 10mg qd;Insulin Glargine Injection qn 16u

YES

9.25

6.6

3.44

0.8

1.65

1.47

S3_6

male

66

21

YES

NE

Dapagliflozin 10mg qd;Acarbose Tablets 50mg tid

YES

8.46

7.4

3.33

0.94

1.22

1.78

S3_8

female

65

20.6

YES

NE

Insulin Aspart 30 Injection acm 22u;acv 20u

YES

8

6.7

4.52

2.45

1.35

2.78

GuoLei

male

40

27.08

NO

NO

NA

NO

16.02

10.4

9.65

5.55

6.36

1.12

S2_10

female

54

20.6

NO

NO

NA

YES

8.9

7.1

4.56

0.69

1.63

2.68

S2_11

female

38

23.15

NO

NO

Metformin 0.5g bid;Acarbose Tablets 50mg tid

YES

8.67

8.9

4.39

0.88

2.9

1.25

S2_15

male

29

24.5

NO

NO

Insulin degludec 14u;Insulin Aspart Injection acm、acl、acv 6u

NO

12

5.4

3.4

0.52

1.59

1.28

S2_17

female

39

20.6

NO

NO

Metformin 0.5g bid;Dapagliflozin 10mg qd

YES

6

6.4

6.57

1.8

0.99

4.61

S2_18

male

30

26.7

NO

NO

Metformin 0.5g bid;Polyethylene Glycol Loxenatide Injection 0.1g qw

YES

11.1

8.1

4.84

4.28

0.99

2.17

S2_19

male

21

24.7

NO

NO

NA

NO

5.35

8.5

4.11

1.2

0.78

2.67

S2_3

male

35

40.54

NO

NO

Linagliptin 5mg qd;Liraglutide Injection 0.6mg qd

YES

12.34

10.8

3.5

6.18

0.99

4.01

S2_4

male

41

22.4

NO

NO

Metformin 0.5g bid;Dapagliflozin 10mg qd

YES

9.57

7.3

4.77

0.73

1.54

3.1

S2_6

female

51

23.65

NO

NO

Metformin 0.5g bid;Empagliflozin 10mg qd;Glimepiride 1mg qd

YES

16.07

8.5

5.21

2.78

1.24

3.09

S2_8

male

42

22.43

NO

NO

NA

NO

7.75

7.9

5.33

2.46

1.02

3.3

S2_9

female

36

24.15

NO

NO

Metformin 0.5g bid;Dapagliflozin 10mg qd

YES

9.23

8.4

5.38

1.44

1.33

3.89

S35_1

male

62

24.8

NO

NO

Metformin 0.5g bid;Dapagliflozin 11mg qd

NO

6.96

6.06

1.79

1.08

3.99

1.28

S134

female

38

23.45

NO

NO

Metformin 0.5g bid;Dapagliflozin 12mg qd

YES

7.37

8.4

5.78

1.69

0.89

4.01

S180

female

69

24.46

NO

NO

NA

YES

7.83

7.8

4.12

1.43

0.95

2.54